Metlife (MET) Price Target Increased to $55.00 by Analysts at Barclays

Metlife (NYSE:MET) had its price objective increased by equities researchers at Barclays from $52.00 to $55.00 in a research note issued on Wednesday, BenzingaRatingsTable reports. The firm presently has an “overweight” rating on the financial services provider’s stock. Barclays‘s price objective would indicate a potential upside of 16.40% from the company’s current price.

Other equities analysts have also recently issued research reports about the company. ValuEngine upgraded Metlife from a “sell” rating to a “hold” rating in a research note on Friday, May 3rd. Wells Fargo & Co reiterated a “buy” rating and issued a $55.00 price objective on shares of Metlife in a research note on Tuesday. UBS Group raised their target price on Metlife from $45.00 to $48.00 and gave the stock a “neutral” rating in a research report on Tuesday, April 9th. Deutsche Bank raised their target price on Metlife from $46.00 to $47.00 and gave the stock a “hold” rating in a research report on Friday, April 12th. Finally, Argus reissued a “buy” rating on shares of Metlife in a research report on Tuesday, February 12th. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and six have issued a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average target price of $51.39.

Shares of MET opened at $47.25 on Wednesday. The company has a debt-to-equity ratio of 0.24, a current ratio of 0.14 and a quick ratio of 0.14. The stock has a market capitalization of $45.74 billion, a PE ratio of 8.77, a P/E/G ratio of 1.01 and a beta of 1.21. Metlife has a 1 year low of $37.76 and a 1 year high of $50.40.

Metlife (NYSE:MET) last announced its quarterly earnings data on Wednesday, May 1st. The financial services provider reported $1.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.30 by $0.18. The business had revenue of $15.45 billion during the quarter, compared to analysts’ expectations of $15.95 billion. Metlife had a return on equity of 10.20% and a net margin of 7.56%. The business’s quarterly revenue was up 2.0% compared to the same quarter last year. During the same quarter last year, the business posted $1.36 EPS. As a group, sell-side analysts expect that Metlife will post 5.61 EPS for the current year.

Several hedge funds and other institutional investors have recently modified their holdings of the company. Wunderlich Capital Managemnt increased its position in Metlife by 0.8% during the first quarter. Wunderlich Capital Managemnt now owns 28,337 shares of the financial services provider’s stock worth $1,206,000 after buying an additional 215 shares during the period. Citizens Financial Group Inc RI increased its position in Metlife by 12.7% during the first quarter. Citizens Financial Group Inc RI now owns 1,945 shares of the financial services provider’s stock worth $83,000 after buying an additional 219 shares during the period. YorkBridge Wealth Partners LLC increased its position in Metlife by 2.7% during the first quarter. YorkBridge Wealth Partners LLC now owns 8,566 shares of the financial services provider’s stock worth $365,000 after buying an additional 224 shares during the period. Parkside Financial Bank & Trust increased its position in Metlife by 14.0% during the first quarter. Parkside Financial Bank & Trust now owns 1,849 shares of the financial services provider’s stock worth $79,000 after buying an additional 227 shares during the period. Finally, Stratos Wealth Partners LTD. increased its position in Metlife by 0.9% during the first quarter. Stratos Wealth Partners LTD. now owns 27,109 shares of the financial services provider’s stock worth $1,154,000 after buying an additional 229 shares during the period. 77.09% of the stock is currently owned by institutional investors and hedge funds.

About Metlife

MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.

See Also: Average Daily Trade Volume – ADTV

Analyst Recommendations for Metlife (NYSE:MET)

Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.